BPA Call VA24917A0027-VA24917J2264
Award Date 4/1/17
Potential Completion Date 10/31/19
Potential Value $1.4M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lexington, KY 40502, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Hepatitis C genotyping and quantitative PCR test kits and reagents for the Abbott M2000 SP/RT Systems. The BPA was issued under the VA's FSS-65-VII contract vehicle for In-Vitro Diagnostics, Reagents, and Test Kits. The award has a potential value of $335,767.18 and a completion date of January 31, 2019. The contract is a firm...
- This is a Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Hepatitis C virus genotyping services. The contract, valued at $196,119.00, is under the VA's Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle for In Vitro Diagnostics, Reagents, and Test Kits (GSA Schedule 65-VII). The contract has a period of performance ending on September 30, 2017 and does not utilize a...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories that provides molecular diagnostic products and services. The contract is for $196,119.00 to provide Hepatitis C virus genotyping services to the VA. The contract is under the GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test Kits, and has an ultimate completion date of September 30, 2016. Abbott Molecular...
- This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Hepatitis C Virus (HCV) genotyping services to the Department of Veterans Affairs (VA). The award, with a ceiling value of $89,610.54, was issued on October 1, 2017 and has an ultimate completion date of September 30, 2018. The contract is a Blanket Purchase Agreement (BPA) call, with a Firm Fixed Price pricing type, under the General Services Administration (GSA) Schedule contract for In...
- This federal contract award, valued at $368,963.17, was issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is for the supply of accessories, reagent kits, consumables, and a maintenance agreement for SARS-CoV-2, hepatitis C virus (HCV), human immunodeficiency virus (HIV), and hepatitis B virus (HBV) polymerase chain reaction (PCR) testing. This contract is a...
- This is a $288,583.83 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is for the provision of accessories, reagent kits, consumables, supplies, and a maintenance agreement for SARS-CoV-2, HCV, HIV, and HBV PCR testing. The contract was awarded under the GSA Schedule 65-VII Invitro Diagnostics, Reagents, Test contract and does not have a set-aside...
- This federal contract award to Abbott Molecular Inc. is for the supply of accessories, reagent kits, consumables, supplies, and a maintenance agreement for SARS-CoV-2, HCV, HIV, and HBV PCR testing. The contract is a Blanket Purchase Agreement (BPA) Call under the General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test. The contract has a ceiling value of $296,287.73 and a performance period through July 31, 2022. The contract was awarded on August 1,...
- This federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, is for the provision of reagent testing supplies and equipment for Hepatitis C (HCV) and venereal disease (VD) testing. The $353,248.96 delivery order was issued by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 4. The contract was not set aside for a specific business category. Abbott Molecular, a manufacturer of molecular diagnostic products...
- This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the U.S. Department of Veterans Affairs (VA) for HCV-HIV viral load tests, including reagents and instrument rental. The contract has a total ceiling value of $2,283,975.75 and is a delivery order under the General Services Administration (GSA) Schedule 65-VII for In-vitro Diagnostics, Reagents, and Test. The contract does not have a set-aside designation. This award supports the VA's healthcare...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for HIV HCV reagents. The contract has a potential value of $193,764.28 and a performance period through December 31, 2020. The contract was issued as a delivery order under the General Services Administration (GSA) Schedule 65-VII for in vitro diagnostics, reagents, and tests. It is a firm-fixed-price contract, and there is no...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- V797D40222-VA24917A0027Blanket Purchase Agreement
- VA24917A0027-VA24917J2264BPA Call
This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for Hepatitis C genotyping and quantitative PCR test kits and reagents for the Abbott M2000 SP/RT diagnostic systems. The contract was awarded on April 1, 2017 as a Blanket Purchase Agreement (BPA) call under the GSA Federal Supply Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits, with a potential value of $1,437,282.00. The contract has a performance period ending on October 31, 2019 and utilizes a Firm Fixed Price pricing type. This award is not designated as a set-aside contract.
Generated 3/22/24, 2:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($962) | 10/24/18 | |
| Not listed | Not listed | $287.6k | 3/30/17 |